A survey of public funding of cancer research in the European Union

PLoS Medicine

Volumn 3, Issue 7, 2006, Pages 0994-0999

  Eckhouse, Seth ^a   Sullivan, Richard ^b  

^a European Cancer Research Managers Forum   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RESEARCH; COST OF ILLNESS; EUROPEAN UNION; FUNDING; HEALTH CARE; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; LUNG CANCER; REVIEW; SMOKING CESSATION; STATISTICAL ANALYSIS; ARTICLE; COMPARATIVE STUDY; ECONOMICS; FINANCIAL MANAGEMENT; INFORMATION PROCESSING; MEDICAL RESEARCH; ONCOLOGY; SOCIAL WELFARE; UNITED STATES;

BIOMEDICAL RESEARCH; CHARITIES; DATA COLLECTION; EUROPEAN UNION; FINANCING, GOVERNMENT; MEDICAL ONCOLOGY; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 33746391933     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0030267     Document Type: Review

References (15)

1. World Health Organization [WHO], International Agency for Research on Cancer [IARC] (2003) World cancer report 2003. Geneva: WHO. Available: http://www.iarc.fr/WCR. Accessed 27 May 2006.
2. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481-488.
3. Callon M (1994) Is science a public good? Sci Tech Human Values 19: 395-424.
4. European Economic and Social Committee (2004) Building our common future - Policy changes and budgetary means of the enlarged Union 2007-2013. Brussels: European Economic and Social Committee. Available: http://www.a-e-r.org/ fileadmin/user_upload/MainIssues/CohesionRegionalPolicy/CESE-opinion-sept-2004. doc. Accessed 27 May 2006.
5. Commission of the European Communities (2004) Science and technology, the key to Europe's future - Guidelines for future European Union policy to support research. Brussels: Commission of the European Communities. Available: http://europa.eu/eur-lex/en/com/cnc/2004/com2004_0353en01.pdf. Accessed 27 May 2006.
6. Commission of the European Communities (2005) Five-year assessment of the European Union research framework programmes 1999-2003. Brussels: Commission of the European Communities. Available: http://www.euractiv.com/29/images/ five_year_assessment_tcm29-135412.pdf. Accessed 27 May 2006.
7. Chu J (2004 January 19) How to plug Europe's brain drain. TIME: 32-39.
8. Commission of the European Communities (2003) Researchers in the European Research Area, one profession, multiple careers. Brussels: Commission of the European Communities. Available: http://www.iua.ie/core_activities/research/pdf/ careercommunication.pdf. Accessed 27 May 2006.
9. Potocnik J, DeHavilland Information Services (2005) Delivering Lisbon: Reforms for the enlarged Union. Brussels: European Economic and Social Committee. Available: http://www.etr2a.org/lib/liDownload/65/ Delivering%20Lisbon.pdf. Accessed 27 May 2006.
10. Kaplan W, Laing R (2004) Priority medicines for Europe and the World. Geneva: Department of Essential Drugs and Medicines Policy, World Health Organization. Report No. WHO/EDM/PAR/2004.7. Available: http://mednet3.who.int/ prioritymeds/report/final18october.pdf. Accessed 27 May 2006.
11. McGeary M, Burstein M (1999) Sources of cancer research funding in the United States. Bethesda: National Cancer Institute. Available: http://www.iom.edu/Object.File/Master/12/783/Fund.pdf. Accessed 27 May 2006.
12. US Department of Health and Human Services (2002) NCI fact book. Bethesda: National Cancer Institute. Available: http://fmb.cancer.gov/financial/ 02factbook.pdf. Accessed 27 May 2006.
13. European Union (2002) The European Union is falling further and further behind in research and competitiveness. Brussels: EUROPA. Available: http://europa.eu.int/rapid/pressReleasesAction.do?reference=IP/02/ 939&format=HTML&aged=0&language=EN&guiLanguage=en. Accessed 27 May 2006
14. Greener M (December 2004) Why does the European biotech sector underperform? EuroBuisness: 48-50.
15. MacLean M, Davies C, Lewison G, Anderson J (1998) Evaluating the research activity and impact of funding agencies. Res Evaluation 7: 7-16.